Kronox Lab Sciences Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 4,785,000 (50%) | — | ₹6,508 Cr |
| NII (HNI) | — | 1,435,500 (15%) | — | ₹1,952 Cr |
| Retail | — | 3,349,500 (35%) | — | ₹4,555 Cr |
| Σ Total | — | 9,570,000 (100%) | — | ₹130,152 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 110 | ₹14,960 |
| Retail (Max) | 13 | 1,430 | ₹194,480 |
| S-HNI (Min) | 14 | 1,540 | ₹209,440 |
| B-HNI (Min) | 67 | 7,370 | ₹1,002,320 |
Financial Statements Amount in Crore
| Metric | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue | 68 | 98 | 83 |
| Profit After Tax | 15 | 17 | 14 |
| Net Worth | 60 | 45 | 40 |
| Total Assets | 67 | 54 | 57 |
| Reserves & Surplus | 16 | 8 | 40 |
| Total Borrowing | — | — | 1 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and –
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India. –
Company Overview
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.
The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.
The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.
The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.
As of December 31, 2023, the company is conducting research and development on 122 products.
The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.
As of December 31, 2023, the company employees 212 people at various levels.